AGMB — Agomab Therapeutics NV Share News
0.000.00%
Last trade - 00:00- $902.61m
- $621.32m
Brief: Agomab Reports Positive Topline Data From Stenova Open-Label Extension Study Of Ontunisertib In Fibrostenosing Crohn's Disease
Brief: Agomab Announces Appointments Of Marino Garcia And Dr Naimish Patel To Board Of Directors
Brief: Agomab Announces Proposed Appointments Of Marino Garcia And Dr. Naimish Patel To Board Of Directors
NASDAQ RESUMED AT 04:00 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:51 PM
U.S. STOCKS ON THE MOVE-SpyGlass, Agomab, Piper Sandler, Molina